Gram-positive Bacterial Infections

Oritavancin for Treatment of Serious Cardiac Infections

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections

Clinical Decision Support Tool for Vancomycin Dosing in Children

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)

Model-informed Precision Dosing for Linezolid

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections

Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition

Dalbavancin Outpatient Pilot

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens.

Controlled Human Infection for Vaccination Against Streptococcus Pyogenes

Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics

A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)

Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients